Mr. Speaker, I have a petition from members of United Senior Citizens of Ontario Inc. who reside in Peterborough. They say that the safety of consumers and senior citizens in particular is at risk because brand name drug manufacturers are attempting to force generic drug manufacturers to market their equivalent products in a size, shape and colour different from the brand name medication.
Any action that affects the look of generic drugs could endanger patient safety through improper use of medicines. Therefore, the petitioners request that Parliament regulate the longstanding Canadian practice of marketing generic drugs in a size, shape and colour which is similar to that of its brand name equivalent.